Review article · 2017 · Open access

Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions

Maocai Yan, Guanqun Li, Jing An

Experimental Biology and Medicine, 242(11), 1185–1197 · Published 5 May 2017 · DOI 10.1177/1535370217708198

Open full textView at the publisherCite this paper

In brief

“Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions” is a 2017 review article by Maocai Yan and 2 co-authors, published in Experimental Biology and Medicine. OpenAlex counts 96 citations as of 21 November 2026, which puts it in the top 7% of works published in 2017 by citations. It is open access: the full text is free to read at Europe PMC (PubMed Central).

Citations
96
Most cited in
2020 (18)
Field-weighted impact
0.94
References
56
Authors
3

Abstract

The Wnt/β-catenin signaling pathway typically shows aberrant activation in various cancer cells, especially colorectal cancer cells. This signaling pathway regulates the expression of a variety of tumor-related proteins, including c-myc and cyclin D1, and plays essential roles in tumorigenesis and in the development of many cancers. Small molecules that block the interactions between β-catenin and Tcf4, a downstream stage of activation of the Wnt/β-catenin signaling pathway, could efficiently cut off this signal transduction and thereby act as a novel class of anticancer drugs. This paper reviews the currently reported inhibitors that target β-catenin/Tcf4 interactions, focusing on the discovery approaches taken in the design of these inhibitors and their bioactivities. A brief perspective is then shared on the future discovery and development of this class of inhibitors. Impact statement This mini-review summarized the current knowledge of inhibitors of interactions of beta-catenin/Tcf4 published to date according to their discovery approaches, and discussed their in vitro and in vivo activities, selectivities, and pharmacokinetic properties. Several reviews presently available now in this field describe modulators of the Wnt/beta-catenin pathway, but are generally focused on the bioactivities of these inhibitors. By contrast, this review focused on the drug discovery approaches taken in identifying these types of inhibitors and provided our perspective on further strategies for future drug discoveries. This review also integrated many recently published and important works on highly selective inhibitors as well as rational drug design. We believe that the findings and strategies summarized in this review have broad implications and will be of interest throughout the biochemical and pharmaceutical research community.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yan, M., Li, G., & An, J. (2017). Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions. Experimental Biology and Medicine, 242(11), 1185–1197. https://doi.org/10.1177/1535370217708198

MLA 9

Yan, Maocai, et al. “Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.” Experimental Biology and Medicine, vol. 242, no. 11, 2017, pp. 1185–1197. https://doi.org/10.1177/1535370217708198.

Chicago

Yan, Maocai, Guanqun Li, and Jing An. 2017. “Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.” Experimental Biology and Medicine 242 (11): 1185–1197. https://doi.org/10.1177/1535370217708198.

Harvard

Yan, M., Li, G. and An, J. (2017) ‘Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions’, Experimental Biology and Medicine, 242(11), pp. 1185–1197. doi:10.1177/1535370217708198.

IEEE

M. Yan, G. Li, and J. An, “Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions,” Experimental Biology and Medicine, vol. 242, no. 11, pp. 1185–1197, 2017, doi: 10.1177/1535370217708198.

BibTeX

@article{yan2017discovery,
  title     = {{Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions}},
  author    = {Yan, Maocai and Li, Guanqun and An, Jing},
  journal   = {Experimental Biology and Medicine},
  year      = {2017},
  volume    = {242},
  number    = {11},
  pages     = {1185--1197},
  doi       = {10.1177/1535370217708198},
  url       = {https://doi.org/10.1177/1535370217708198}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201722
201888
20191212
20201818
20211515
202299
202333
20241212
202577
20261010

Its field-weighted citation impact is 0.94: it has been cited 0.94 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer

  • Wnt/β-catenin signaling
  • small molecule inhibitors
  • protein-protein interaction inhibitors
  • colorectal cancer
  • anticancer drug discovery
  • rational drug design
  • pharmacokinetics
  • inhibitor selectivity

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Yan, M., Li, G., & An, J. (2017). Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions. Experimental Biology and Medicine, 242(11), 1185–1197. https://doi.org/10.1177/1535370217708198

How many times has this paper been cited?

96 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.

Who wrote this paper?

Maocai Yan, Guanqun Li, Jing An.

What is the DOI of this paper?

10.1177/1535370217708198, permanently at https://doi.org/10.1177/1535370217708198. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.